The Medical Travel Company (TMTC) is making strides in facilitating medical travel between the UK and India with its recent €3.8 million funding. This UK and India-based startup aims to offer UK patients world-class treatments at affordable rates in India, addressing the prolonged wait times faced by many in the UK for elective surgeries. In bringing cost-effective healthcare solutions to those in need, TMTC hopes to provide a structured and reliable medical experience abroad.
Just a few years ago, medical tourism was fraught with concerns regarding quality and reliability. Many questioned the viability of seeking treatment abroad due to inconsistent standards and lack of transparency. TMTC’s initiative focuses on bridging such gaps, providing a transparent and high-quality healthcare option with involved UK doctors. While the medical tourism landscape has shown fragmented growth historically, TMTC distinguishes itself with its comprehensive service that includes full logistical support and post-operative care.
How Does TMTC Address Existing Gaps?
TMTC’s approach centers around a full-stack platform that ensures convenient and high-quality medical travel for UK patients to India. The company collaborates closely with UK doctors throughout the treatment process to offer continuity of care. Transparency in pricing, combined with personalized recovery services, sets TMTC apart in the fragmented medical tourism sector. They have reported consistent growth and are gaining industry recognition for their structured approach to facilitating cross-border healthcare.
What Are the Plans for the New Funding?
With its recent funding boost, TMTC intends to enhance its clinical collaborations within the UK, bolstering patient trust and establishing secure medical travel pathways. The company also aims to develop technology that enables complete medical record maintenance, aiding in smooth continuity of care for returning patients. Such initiatives are crucial in an industry where over half a million UK residents travel abroad yearly for medical procedures due to prohibitive local costs.
Founded by Sahil Jain and Ankit Mehrotra, TMTC is the brainchild of entrepreneurs who recognize the increasing demand for affordable and accessible healthcare solutions. With over 7.7 million people in the UK waiting for elective procedures and private care costs skyrocketing, TMTC’s service meets a significant need. The company’s commitment to quality is reflected in its choice of internationally-trained clinicians and globally accredited hospitals, providing a structured and reliable healthcare model.
In the future, TMTC plans to expand to cover various specialties like orthopedics, dental services, IVF, and more. Investments from entities like Nexus Venture Partners and 4CAST reinforce confidence in the startup’s potential to reshape medical travel. By connecting patients to globally accredited hospitals and providing extensive post-surgery insurance back in the UK, they ensure a safe and secure journey for their users.
TMTC also focuses on addressing aftercare challenges, traditionally a concern for patients seeking treatment abroad. By aligning with private hospitals in the UK and providing personalized aftercare and logistics, the company ensures a seamless transition for patients post-treatment. This strategic move addresses a significant concern in the current medical tourism framework.
TMTC is poised to redefine how UK patients access international healthcare. As wait times rise and private healthcare becomes increasingly unaffordable, TMTC’s model provides an organized alternative. The company’s efforts cater to core patient needs through clinical precision and a transparent service model.
